Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

4-hydroxytoremifene

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
While estrogen receptor (ER)-targeted therapeutics have clearly been a success in the treatment of breast cancer, the orphan… 
2004
2004
Estrogen-related receptor gamma (ERRgamma) is an orphan nuclear receptor lacking identified natural ligands. We have addressed… 
2004
2004
SummaryA multicenter phase I pharmacokineticstudy of a new triphenylethylene antiestrogen, toremifene, was examined in 70… 
  • figure 2
  • figure 1
  • table 1
  • figure 4
  • figure 3
2004
2004
  • L. Kangas
  • Cancer Chemotherapy and Pharmacology
  • 2004
  • Corpus ID: 11502291
SummaryToremifene, a new antiestrogenic antitumor compound, has several biologically active metabolites. The hormonal effects of… 
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 5
2003
2003
The antiestrogen, tamoxifen, has been extensively used in the treatment and prevention of breast cancer. Although tamoxifen… 
2002
2002
The in vitro metabolism of toremifene has been studied in liver microsomal preparations from rat, mouse and human sources using… 
2001
2001
Tamoxifen remains the endocrine therapy of choice in the treatment of all stages of hormone-dependent breast cancer. However… 
Highly Cited
2000
Highly Cited
2000
Tamoxifen is widely prescribed for the treatment of hormone-dependent breast cancer, and it has recently been approved by the… 
1997
1997
Abstract The aim of the present study was to investigate antioxidativity of the triphenylethylene antiestrogen toremifene… 
  • table 1
  • figure 1
  • figure 4
1997
1997
Tamoxifen and its analogues 4-hydroxytamoxifen, toremifene, 4-hydroxytoremifene, clomifene and droloxifene were tested for…